Research Project
Grant-in-Aid for Young Scientists (B)
Intratumor heterogeneity causes therapy resistance of cancer. Advanced colorectal cancer harbors extensive intratumor heterogeneity shaped by neutral evolution. We performed multiregion whole-exome sequencing on 10 early colorectal tumors, which contained adenoma and carcinoma in situ. By comparing with sequencing data from advanced colorectal tumors, we found that the early tumors accumulated a higher proportion of subclonal driver mutations than the advanced tumors. We also observed that variant allele frequencies of subclonal mutations tended to be higher in early tumors, suggesting that the subclonal mutations were subject to selective sweep in early tumorigenesis while neutral evolution is dominant in advanced ones. This study establishes that the evolutionary principle underlying intratumor heterogeneity shifts from Darwinian to neutral evolution during colorectal tumor progression.
All 2017 2016
All Journal Article (3 results) (of which Peer Reviewed: 3 results, Open Access: 2 results) Presentation (2 results)
Anticancer Res.
Volume: 37(5) Pages: 2365-2371
Ann Surg Oncol.
Volume: 24(3) Issue: 3 Pages: 850-859
10.1245/s10434-016-5573-9
PLoS One.
Volume: 11(11) Issue: 11 Pages: e0165912-e0165912
10.1371/journal.pone.0165912